Old Web
English
Sign In
Acemap
>
authorDetail
>
Hirofumi Ogura
Hirofumi Ogura
GlaxoSmithKline
Medicine
Pharmacokinetics
Tolerability
Internal medicine
Adverse effect
8
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Single-Dose, Open-Label, Randomized, Two-Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat.
2020
Clinical pharmacology in drug development
Masanori Yamada
Minori Osamura
Hirofumi Ogura
Tomohiro Onoue
Akira Wakamatsu
Yotaro Numachi
Stephen Caltabiano
Kelly M. Mahar
Show All
Source
Cite
Save
Citations (1)
Evaluation of the Safety, Tolerability, and Pharmacokinetics of GSK2269557 (Nemiralisib) Administered Via Dry Powder Inhaler to Healthy Japanese Subjects
2019
Clinical pharmacology in drug development
Hiroko Ino
Robert Wilson
Takumi Terao
Hirofumi Ogura
Harue Igarashi
Anthony Cahn
Yotaro Numachi
Show All
Source
Cite
Save
Citations (4)
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluations Following Single Oral Doses of GSK2330672 in Healthy Japanese Volunteers
2019
Clinical pharmacology in drug development
Hiroko Ino
Akira Endo
Akira Wakamatsu
Hirofumi Ogura
Yotaro Numachi
Stuart Kendrick
Show All
Source
Cite
Save
Citations (3)
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Food Effect of Danirixin Hydrobromide Tablets in Japanese Healthy Elderly Participants
2019
Clinical pharmacology in drug development
Takayuki Iida
Yuki Matsuzawa
Hirofumi Ogura
Takashi Nagakubo
Akira Wakamatsu
Claire Ambery
Bruce E. Miller
Aili L. Lazaar
Yotaro Numachi
Show All
Source
Cite
Save
Citations (0)
1